Related Experiment Video

Updated: Jul 2, 2025

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K

The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy

Nicholas S Giacobbi1, Shreya Mullapudi1, Harrison Nabors1

  • 1Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA.

Viruses
|February 24, 2024
PubMed

Insights

Chemokines like CXCL14 show promise for cancer immunotherapy by boosting antitumor immunity. Further research is needed to understand CXCL14

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Chemokines are key regulators of immune responses and potential targets for cancer therapy.
  • Previous research indicates that the chemokine CXCL14 possesses antitumor properties.
  • The precise mechanisms and therapeutic applications of CXCL14 in cancer remain under investigation.

Purpose of the Study:

  • To review the current understanding of CXCL14's role in cancer progression.
  • To discuss the potential of CXCL14 as an immunotherapeutic agent for cancer treatment.
  • To highlight areas requiring further research for clinical application of CXCL14.

Main Methods:

  • Literature review of existing studies on CXCL14 and cancer.
  • Analysis of chemokine signaling pathways in the context of antitumor immunity.
  • Discussion of preclinical and clinical considerations for CXCL14-based therapies.

Main Results:

  • CXCL14 demonstrates potential in promoting antitumor immune responses.
  • Understanding CXCL14's mechanism of action is crucial for its therapeutic development.
  • Optimal delivery methods, dosage, and combination therapies require further elucidation.

Conclusions:

  • CXCL14 is a promising candidate for novel cancer immunotherapies.
  • Translating CXCL14's potential into effective clinical treatments requires addressing key knowledge gaps.
  • Future research should focus on elucidating mechanisms, optimizing delivery, and exploring combination strategies.
Keywords:
CXCL14chemokineimmunotherapy

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 406:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

13.7K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367